Abstract
This paper describes the psychometric properties of two fidelity scales created as part of the Substance Abuse and Mental Health Services Administration (SAMHSA) sponsored medication management toolkit and their metric properties when used in 26 public mental health clinics with 50 prescribers. A 23-item scale, based on chart reviews, was developed to assess whether prescribers are following good medication practices, in conjunction with a 17-item scale to assess organizational support for and evaluation of prescriber adherence to recommended medication-related practices. Fundamental gaps in routine practice, including poor documentation of medication history and infrequent monitoring of symptoms and side effects were found.
Original language | English |
---|---|
Pages (from-to) | 247-254 |
Number of pages | 8 |
Journal | Administration and Policy in Mental Health and Mental Health Services Research |
Volume | 36 |
Issue number | 4 |
DOIs | |
State | Published - Jul 2009 |
Bibliographical note
Funding Information:Mt. Sinai School of Medicine). Scale testing was funded by unrestricted educational grants from AstraZeneca, Bristol Myers Squibb, Janssen, Lilly, and Pfizer to Dr. Miller. Initial development of the scale was funded by a contract between Dartmouth Medical School and the Substance Abuse and Mental Health Services Administration for development of evidence-based practice toolkits, with the medication toolkit subcontracted to the University of Texas Health Science Center at San Antonio.
Keywords
- Antipsychotics
- Fidelity measurement
- Medication management
ASJC Scopus subject areas
- Psychiatric Mental Health
- Health Policy
- Public Health, Environmental and Occupational Health
- Psychiatry and Mental health